Company intelligence / Profile preview

BPI Labs

Largo, Florida, United States

Ownership: Private
Employees: ~150
Development stage: Other

Overview

BPI Labs develops and manufactures FDA-approved generic injectables, specializing in sterile stocks for critical drug shortages. Seven branded injectable generics are FDA approved, with one additional product at tentative approval stage. Manufacturing is compliant with cGMP, highly automated, and robotically controlled

Therapeutic areas: ImmunologyOncologyCardiovascular
Modalities: Small moleculeAlcoholPeptides
Industry: Biotech

Beyond the preview

Go deeper on BPI Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BPI Labs.

Explore the full profile